Skip to main content

Advertisement

SpringerLink
Log in

Alternative and Complementary Treatments for Metabolic Syndrome

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Metabolic syndrome is defined by a cluster of cardiovascular disease risk factors that are associated with insulin resistance. In recent years, a number of innovative nutritional strategies have been proposed as safe alternative treatments to reduce the morbidity as well as the cost of treating metabolic syndrome. Of these, dietary supplementation with chromium picolinate or cinnamon extract has been studied most extensively. These interventions may attenuate insulin resistance and reduce the cardiovascular risk factors that together comprise the metabolic syndrome. However, more clinical trials are needed to determine the dose and duration of such treatments to make specific recommendations for populations with metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •   Of importance

  1. Pratley RE. Metabolic syndrome: why the controversy? Curr Diab Rep. 2007;7:56–9.

    Article  PubMed  Google Scholar 

  2. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III) [no authors listed]. JAMA 2001, 285:2486–2497.

    Google Scholar 

  3. Jeejeebhoy KN, Chu RC, Marliss EB, et al. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr. 1977;30:531–8.

    PubMed  CAS  Google Scholar 

  4. Via M, Scurlock C, Raikhelkar J, et al. Chromium infusion reverses extreme insulin resistance in a cardiothoracic ICU patient. Nutr Clin Pract. 2008;23:325–8.

    Article  PubMed  Google Scholar 

  5. Anderson RA. Chromium and parenteral nutrition. Nutrition. 1995;11:83–6.

    PubMed  CAS  Google Scholar 

  6. Anderson RA. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr. 1997;16:404–10.

    PubMed  CAS  Google Scholar 

  7. Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998;17:548–55.

    PubMed  CAS  Google Scholar 

  8. National Research Counsil, Food and Nutrition Board. Recommended dietary allowances. 10th ed. Washington: National Academy Press; 1989.

    Google Scholar 

  9. Anderson RA, Polansky MM, Bryden NA, et al. Effects of chromium supplementation on urinary Cr excretion of human subjects and correlation of Cr excretion with selected clinical parameters. J Nutr. 1983;113:276–81.

    PubMed  CAS  Google Scholar 

  10. Bunker VW, Lawson MS, Delves HT, Clayton BE. The uptake and excretion of chromium by the elderly. Am J Clin Nutr. 1984;39:797–802.

    PubMed  CAS  Google Scholar 

  11. Anderson RA, Kozlovsky AS. Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am J Clin Nutr. 1985;41:1177–83.

    PubMed  CAS  Google Scholar 

  12. Offenbacher EG. Promotion of chromium absorptionby ascorbic acid. Trace Elem Electrolytes. 1994;11:178.

    CAS  Google Scholar 

  13. Lim TH, Sargent 3rd T. Kusubov N: Kinetics of trace element chromium(III) in the human body. Am J Physiol. 1983;244:R445–54.

    PubMed  CAS  Google Scholar 

  14. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys. 1959;85:292–5.

    Article  PubMed  CAS  Google Scholar 

  15. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33:503–10.

    Article  PubMed  CAS  Google Scholar 

  16. Hummel M, Standl E, Schnell O. Chromium in metabolic and cardiovascular disease. Horm Metab Res. 2007;39:743–51.

    Article  PubMed  CAS  Google Scholar 

  17. Cefalu WT, Hu FB. Role of chromium in human health and in diabetes. Diab Care. 2004;27:2741–51.

    Article  CAS  Google Scholar 

  18. Cefalu WT, Wang ZQ, Zhang XH, et al. Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr. 2002;132:1107–14.

    PubMed  CAS  Google Scholar 

  19. Sherman L, Glennon JA, Brech WJ, et al. Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism. 1968;17:439–42.

    Article  PubMed  CAS  Google Scholar 

  20. Rabinowitz MB, Gonick HC, Levin SR, Davidson MB. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diab Care. 1983;6:319–27.

    Article  CAS  Google Scholar 

  21. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diab Care. 1994;17:1449–52.

    Article  CAS  Google Scholar 

  22. Thomas VL, Gropper SS. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors. Biol Trace Elem Res. 1996;55:297–305.

    Article  PubMed  CAS  Google Scholar 

  23. Trow LG, Lewis J, Greenwood RH, et al. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res. 2000;70:14–8.

    Article  PubMed  CAS  Google Scholar 

  24. Gunton JE, Cheung NW, Hitchman R, et al. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diab Care. 2005;28:712–3.

    Article  Google Scholar 

  25. Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786–91.

    Article  PubMed  CAS  Google Scholar 

  26. Cefalu WT, Bell-Farrow AD, Stegner J, Wang ZQ, King T, Morgan T, et al. Effect of chromium picolinate on insulin sensitivity in vivo. J Trace Elem Exp Med. 1999;12:71–83.

    Article  CAS  Google Scholar 

  27. Iqbal N, Cardillo S, Volger S, et al.: Chromium Picolinate Does Not Improve Key Features of Metabolic Syndrome in Obese Nondiabetic Adults. Metab Syndr Relat Disord 2009.

  28. Lukaski HC, Bolonchuk WW, Siders WA, Milne DB. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nutr. 1996;63:954–65.

    PubMed  CAS  Google Scholar 

  29. Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997;29:992–8.

    PubMed  CAS  Google Scholar 

  30. Martin J, Wang ZQ, Zhang XH, et al. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diab Care. 2006;29:1826–32.

    Article  CAS  Google Scholar 

  31. Proctor SD, Kelly SE, Stanhope KL, et al. Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diab Obes Metab. 2007;9:87–95.

    Article  CAS  Google Scholar 

  32. Roeback Jr JR, Hla KM, Chambless LE, Fletcher RH. Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial. Ann Intern Med. 1991;115:917–24.

    PubMed  Google Scholar 

  33. Abraham AS, Brooks BA, Eylath U. The effects of chromium supplementation on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism. 1992;41:768–71.

    Article  PubMed  CAS  Google Scholar 

  34. Padmavathi IJ, Rao KR, Venu L, et al. Chronic maternal dietary chromium restriction modulates visceral adiposity: probable underlying mechanisms. Diabetes. 2010;59:98–104.

    Article  PubMed  CAS  Google Scholar 

  35. Dugoua JJ, Seely D, Perri D, et al. From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol. 2007;85:837–47.

    Article  PubMed  CAS  Google Scholar 

  36. Anderson RA, Broadhurst CL, Polansky MM, et al. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem. 2004;52:65–70.

    Article  PubMed  CAS  Google Scholar 

  37. Imparl-Radosevich J, Deas S, Polansky MM, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res. 1998;50:177–82.

    Article  PubMed  CAS  Google Scholar 

  38. Qin B, Nagasaki M, Ren M, et al. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diab Res Clin Pract. 2003;62:139–48.

    Article  Google Scholar 

  39. Qin B, Nagasaki M, Ren M, et al. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res. 2004;36:119–25.

    Article  PubMed  CAS  Google Scholar 

  40. Sheng X, Zhang Y, Gong Z, et al. Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res. 2008;2008:581348.

    PubMed  Google Scholar 

  41. Khan A, Safdar M, Ali Khan MM, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diab Care. 2003;26:3215–8.

    Article  Google Scholar 

  42. Vanschoonbeek K, Thomassen BJ, Senden JM, et al. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. 2006;136:977–80.

    PubMed  CAS  Google Scholar 

  43. • Crawford P: Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009, 22:507–512. This is a recent clinical trial demonstrating positive effect of cinnamon extract on HbA 1c levels in people with type 2 diabetes.

    Article  PubMed  Google Scholar 

  44. Ziegenfuss TN, Hofheins JE, Mendel RW, et al. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006;3:45–53.

    Article  PubMed  Google Scholar 

  45. Feiner JJ, McNurlan MA, Ferris RE, et al. Chromium picolinate for insulin resistance in subjects with HIV disease: a pilot study. Diab Obes Metab. 2008;10:151–8.

    CAS  Google Scholar 

  46. Wang JG, Anderson RA, Graham 3rd GM, et al. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Fertil Steril. 2007;88:240–3.

    Article  PubMed  Google Scholar 

  47. Solomon TP, Blannin AK. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diab Obes Metab. 2007;9:895–901.

    Article  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Nutrition and Food Science Department, University of Vermont, Colchester Research Facility, Room 110, 208 South Park Drive, Colchester, VT, 05446, USA

    Mariya Power

  2. College of Medicine, Endocrinology, Diabetes and Metabolism Unit, University of Vermont, Colchester Research Facility, Room 110, 208 South Park Drive, Colchester, VT, 05446, USA

    Richard Pratley

Authors
  1. Mariya Power
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard Pratley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mariya Power.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Power, M., Pratley, R. Alternative and Complementary Treatments for Metabolic Syndrome. Curr Diab Rep 11, 173–178 (2011). https://doi.org/10.1007/s11892-011-0184-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-011-0184-0

Keywords

Search

Navigation